Brief: Pherecydes Pharma Granted New Patent For Its Anti-Pseudomonas Aeruginosa Phages In Europe
22/03/2022 06:04
March 22 (Reuters) - Pherecydes Pharma SA ALPHE.PA :
* PHERECYDES PHARMA GRANTED A NEW PATENT FOR ITS
ANTI-PSEUDOMONAS
AERUGINOSA PHAGES IN EUROPE
* NEW PATENT GRANTED IN EUROPE GIVES COMPANY PROTECTION
UNTIL 2034
ON THIS VAST MARKET
Source text for Eikon: ID:nBw7JDq88a
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes